Logo
Conferences

Conferences

Catalog

Abstracts

Calendar

2026 Memphis Hematologic Malignancies Symposium conference hero image

2026 Memphis Hematologic Malignancies Symposium

Accreditation: 4.50 ABIM MOC II | 4.50 AMA PRA Category 1 Credit™ | 4.50 ACPE Pharmacy | 4.50 Nursing Contact Hours

Venue: Memphis Riverline Hotel, 250 North Main Street, Memphis, TN, United States

Start Date:
Register for Conference

Official conference page for 2026 Memphis Hematologic Malignancies Symposium.

About 2026 Memphis Hematologic Malignancies Symposium

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Binay Shah
13+
Email if you have questions

Faculty and committee

Our Speakers

Planning Committee

Binay Shah

Binay Shah, MD, MHA

Conference Director

Binayatara

Swapna Thota

Swapna Thota, MD

Conference Co-Chair

UTHSC- Memphis

Jeff Harris

Jeff Harris, MD

Conference Co-Chair

Jason Chandler

Jason Chandler, MD

Conference Co-Chair

Faculty

Salil Goorha

Salil Goorha, MD

Topic Presenter

Baptist Cancer Center

Alaa Altahan

Alaa Altahan, MD

Topic Presenter

Emily Curran

Emily Curran , MD

Topic Presenter

Stephen Strickland

Stephen Anthony Strickland, MD

Topic Presenter

Abdullah Khan

Abdullah Khan, MBBS

Topic Presenter

Carolina Schinke

Carolina Schinke, MD

Topic Presenter

Jonathan Blackmon

Jonathan Blackmon, MD

Topic Presenter

Clesheree Stepter

Clesheree Stepter, NP

Case Presenter

Ashwin Kishtagari

Ashwin Kishtagari, MD

Faculty

Vanderbilt University Medical Center

Pallawi Torka

Pallawi Torka, MD

Faculty

Memorial Sloan Kettering Cancer Center

Conference program and agenda

Our Agenda

Saturday, August 22nd, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

07:10 AM - 08:10 AMRegistration, Breakfast, & Exhibits
08:10 AM - 08:15 AMWelcome
08:15 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities
08:30 AM - 10:00 AMSession 1: Myeloma

Session Chair: Jason Chandler, MD

08:30 AM - 08:50 AM

CAR-T vs BiTE Therapy – Carolina Schinke, MD

08:50 AM - 09:10 AM

Whether to transplant or not to transplant – Salil Goorha, MD

09:10 AM - 09:30 AM

Using MRD to stop maintenance? – Abdullah Khan, MBBS

09:30 AM - 10:00 AM

Case based panel discussion – Jason Chandler, MD

10:00 AM - 10:10 AMBreak & Exhibits
10:10 AM - 11:40 AMSession 2: Lymphoma

Session Chair: Jeff Harris, MD

10:10 AM - 10:30 AM

CLL: Time-limited or Continous? – Alaa Altahan, MD

10:30 AM - 10:50 AM

The evolving treatment landscape in relapsed/refractory DLBCL – Pallawi Torka, MD

10:50 AM - 11:10 AM

Chemo-free Approach to ALL – Emily Curran , MD

11:10 AM - 11:40 AM

Case based panel discussion – Clesheree Stepter, NP

11:40 AM - 01:10 PMSession 3: Myeloid

Session Chair: Swapna Thota, MD

11:40 AM - 12:00 PM

Who would you currently induce for AML in 2026? – Stephen Anthony Strickland, MD

12:00 PM - 12:20 PM

Germline Predisposition for Adults – Swapna Thota, MD

12:20 PM - 12:40 PM

Clonal Hematopoiesis and Current Treatment Algorithms – Ashwin Kishtagari, MD

12:40 PM - 01:10 PM

Case based panel discussion – Jonathan Blackmon, MD

01:10 PM - 02:10 PMLunch & Exhibits
02:10 PM - 02:10 PMAdjourn

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship